QIPT Valuation

Quipt Home Medical Corp

Add to Watchlist

Advanced Chart

2.620

+0.01(0.383%)1D

Overview
Forecast
Valuation
Earnings

QIPT Relative Valuation

QIPT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, QIPT is overvalued; if below, it's undervalued.

Historical Valuation

Quipt Home Medical Corp (QIPT) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.35 is considered Undervalued compared with the five-year average of 3.16. The fair price of Quipt Home Medical Corp (QIPT) is between 5.17 to 10.21 according to relative valuation methord. Compared to the current price of 2.56 USD , Quipt Home Medical Corp is Undervalued By 50.34%.

Relative Value

Fair Zone

5.17-10.21

Current Price：2.56

50.34%

Undervalued

-15.20

Trailing

Forward

2.92

EV/EBITDA

Quipt Home Medical Corp. (QIPT) has a current EV/EBITDA of 2.92. The 5-year average EV/EBITDA is 4.79. The thresholds are as follows: Strongly Undervalued below 1.89, Undervalued between 1.89 and 3.34, Fairly Valued between 6.24 and 3.34, Overvalued between 6.24 and 7.68, and Strongly Overvalued above 7.68. The current Forward EV/EBITDA of 2.92 falls within the Undervalued range.

-118.85

EV/EBIT

Quipt Home Medical Corp. (QIPT) has a current EV/EBIT of -118.85. The 5-year average EV/EBIT is 25.27. The thresholds are as follows: Strongly Undervalued below -48.69, Undervalued between -48.69 and -11.71, Fairly Valued between 62.25 and -11.71, Overvalued between 62.25 and 99.23, and Strongly Overvalued above 99.23. The current Forward EV/EBIT of -118.85 falls within the Strongly Undervalued range.

0.35

Quipt Home Medical Corp. (QIPT) has a current PS of 0.35. The 5-year average PS is 0.92. The thresholds are as follows: Strongly Undervalued below 0.06, Undervalued between 0.06 and 0.49, Fairly Valued between 1.35 and 0.49, Overvalued between 1.35 and 1.77, and Strongly Overvalued above 1.77. The current Forward PS of 0.35 falls within the Undervalued range.

0.00

P/OCF

Quipt Home Medical Corp. (QIPT) has a current P/OCF of 0.00. The 5-year average P/OCF is 5.02. The thresholds are as follows: Strongly Undervalued below -2.62, Undervalued between -2.62 and 1.20, Fairly Valued between 8.84 and 1.20, Overvalued between 8.84 and 12.66, and Strongly Overvalued above 12.66. The current Forward P/OCF of 0.00 falls within the Undervalued range.

0.00

P/FCF

Quipt Home Medical Corp. (QIPT) has a current P/FCF of 0.00. The 5-year average P/FCF is 9.81. The thresholds are as follows: Strongly Undervalued below -10.81, Undervalued between -10.81 and -0.50, Fairly Valued between 20.11 and -0.50, Overvalued between 20.11 and 30.42, and Strongly Overvalued above 30.42. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Quipt Home Medical Corp (QIPT) has a current Price-to-Book (P/B) ratio of 0.91. Compared to its 3-year average P/B ratio of 1.66 , the current P/B ratio is approximately -45.08% higher. Relative to its 5-year average P/B ratio of 2.58, the current P/B ratio is about -64.63% higher. Quipt Home Medical Corp (QIPT) has a Forward Free Cash Flow (FCF) yield of approximately 25.62%. Compared to its 3-year average FCF yield of 18.65%, the current FCF yield is approximately 37.32% lower. Relative to its 5-year average FCF yield of 14.63% , the current FCF yield is about 75.14% lower.

1.11

P/B

Median3y

1.66

Median5y

2.58

25.62

FCF Yield

Median3y

18.65

Median5y

14.63

Competitors Valuation Multiple

The average P/S ratio for QIPT's competitors is 1.33, providing a benchmark for relative valuation. Quipt Home Medical Corp Corp (QIPT) exhibits a P/S ratio of 0.35, which is -73.84% above the industry average. Given its robust revenue growth of -4.07%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

QIPT.O

Quipt Home Medical Corp

National Research Corp

Quest Diagnostics Inc

1.83

15.19%

20.17B

Performance Decomposition

Market capitalization of QIPT decreased by 8.39% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -2.63 to -5.19.

The secondary factor is the Revenue Growth, contributed -4.07%to the performance.

Overall, the performance of QIPT in the past 1 year is driven by Margin Expansion. Which is more sustainable.

-4.07%

60.76M → 58.29M

Revenue Growth

97.34%

-2.63 → -5.19

Margin Expansion

-101.66%

656.72 → -10.90

P/E Change

-8.39%